A vasoactive drug as a risk to pregnancy outcome

Am J Obstet Gynecol. 1995 Jun;172(6):1945-6. doi: 10.1016/0002-9378(95)91445-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Abnormalities, Drug-Induced*
  • Animals
  • Arginine / analogs & derivatives*
  • Arginine / toxicity
  • Female
  • Fetal Growth Retardation / chemically induced
  • Hindlimb / abnormalities*
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide / antagonists & inhibitors*
  • Pregnancy
  • Pregnancy Outcome
  • Rats

Substances

  • Nitric Oxide
  • Arginine
  • NG-Nitroarginine Methyl Ester